Division of Lung Transplant and Lung Failure, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Transplantation. 2023 Jul 1;107(7):1440-1451. doi: 10.1097/TP.0000000000004480. Epub 2023 Jun 20.
Only using brain-dead donors with standard criteria, the existing donor shortage has never improved in lung transplantation. Currently, clinical efforts have sought the means to use cohorts of untapped donors, such as extended criteria donors, donation after circulatory death, and donors that are ABO blood group incompatible, and establish the evidence for their potential contribution to the lung transplant needs. Also, technical maturation for using those lungs may eliminate immediate concerns about the early posttransplant course, such as primary graft dysfunction or hyperacute rejection. In addition, recent clinical and preclinical advances in ex vivo lung perfusion techniques have allowed the safer use of lungs from high-risk donors and graft modification to match grafts to recipients and may improve posttransplant outcomes. This review summarizes recent trends and accomplishments and future applications for expanding the donor pool in lung transplantation.
仅使用符合标准的脑死亡供体,现有的供体短缺问题在肺移植中从未得到改善。目前,临床工作已经在寻找使用未开发供体群体的方法,如扩展标准供体、循环死亡后捐献和 ABO 血型不相容供体,并为其对肺移植需求的潜在贡献建立证据。此外,使用这些肺的技术成熟度可能消除对移植后早期过程的即时担忧,如原发性移植物功能障碍或超急性排斥反应。此外,体外肺灌注技术的最近临床和临床前进展使高危供体的肺的使用更加安全,并可对移植物进行修饰以匹配供体和受体,从而可能改善移植后的结果。这篇综述总结了扩大肺移植供体库的最新趋势、成就和未来应用。